Sutro Biopharma's Series B Round

Sutro Biopharma raised a round of funding on March 16, 2009.

Sutro Biopharma is developing a new generation of antibody drug conjugate therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies. These therapeutics will significantly…

Articles about Sutro Biopharma's Series B Round: